Quinn Anthony G.
- SEC CIK
- 0001532219
No open-market purchases or sales filed in the past year.
Current role at each company
- GBIO Generation Bio Co.Directoras of Feb 9, 2026
- SYRE Spyre Therapeutics, Inc.President & CEOas of Mar 18, 2022
- KLDO Kaleido Biosciences, Inc.Directoras of Jul 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Quinn Anthony G. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GBIO Generation Bio Co.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Quinn Anthony G.Director | PPurchase | +88.5K | $1.41 | +$124.8K | New position88.5K after | |
| Jan 14, 2025 (view filing) | Jan 10-13 | 4 days | Quinn Anthony G.Director | PPurchase | +210.8K | $0.964 | +$203.2K | +238.2%299.3K after | 2 lots |
SYRE Spyre Therapeutics, Inc.
President & CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 (view filing) | Dec 9-10 | 4 days | Quinn Anthony G.President & CEO | PPurchase | +53.6K | $3.71 | +$199.0K | +19.5%328.8K after | 2 lots |
| Mar 15, 2022 (view filing) | Mar 11-15 | 4 days | Quinn Anthony G.President & CEO | PPurchase | +144.7K | $1.94 | +$280.8K | +44.0%473.5K after | 3 lots |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Quinn Anthony G.President & CEO | PPurchase | +80.1K | $2.34 | +$187.4K | +17.0%550.5K after |